FDA: Approved Ryoncil Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease in Pediatric Patients 2 Months of Age & Older
FDA:批准Ryoncil治疗2个月及以上儿童类固醇耐药急性移植物抗宿主病
FDA: Approved Ryoncil Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease in Pediatric Patients 2 Months of Age & Older
FDA:批准Ryoncil治疗2个月及以上儿童类固醇耐药急性移植物抗宿主病
使用浏览器的分享功能,分享给你的好友吧